EUVIMEDEUVIMED entdecken
Crossref

Kidney Retransplantation in the Elderly: Are the Benefits Worth the Risks?

Syed S Mujtahedi iD, Colleen L Jay iD, Natalia Sakhovskaya, Amber Reeves-Daniel, Alejandra Mena-Gutierrez, Christopher J Webb, Emily K E McCracken, Alan C Farney, Giuseppe Orlando iD, Jigish Vyas, Arianna Cabrales, Robert J Stratta iD

Clinical Transplantation · 2025

DOI: 10.1111/ctr.70129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2025. Verfasst von Syed S Mujtahedi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Section of Transplantation, Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Reoperation, Graft Rejection, Kidney Failure, Chronic. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

An increasing number of elderly patients are undergoing either primary kidney transplantation (PrKT) or retransplantation (ReKT).

Methods

Single‐center retrospective cohort study of all deceased donor KTs (DDKTs) performed in elderly patients (age ≥65 years).

Results

From December 2004 through August 2022, we performed 668 DDKTs in elderly patients including 39 ReKTs and 629 PrKTs. Mean donor age was lower in the ReKT group (44 ± 17 ReKT vs. 54 ± 13 years PrKT), as was KDPI (58 ± 24 vs. 74 ± 21% PrKT, both p < 0.05). A total of 44% of ReKT patients had a cPRA level above 50% compared to 10.3% PrKT ( p < 0.0001). Rates were comparable between groups for primary nonfunction (2.6% ReKT vs. 3.7% PrKT) and delayed graft function (23% ReKT vs. 32% PrKT, p = 0.29). Five‐year patient (55.2% ReKT vs. 74.3% PrKT, p = 0.03) and graft survival rates (GSRs, 55.2% ReKT vs. 64.7% PrKT, p = 0.32) were higher in the PrKT group. Death with functioning graft (DWFG) occurred in 59% of ReKT versus 37.4% of PrKT patients ( p = 0.01) and accounted for 79.3% ReKT and 65.3% PrKT graft losses. Death‐censored GSRs were not different (62.5% ReKT vs. 68.3% PrKT, p = 0.6).

Conclusions

Elderly recipients of deceased donor ReKTs have a higher risk of DWFG, but death‐censored outcomes are comparable to age‐matched PrKT recipients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationReoperationGraft RejectionKidney Failure, ChronicTissue DonorsPostoperative ComplicationsDelayed Graft FunctionHumansRetrospective StudiesMaleFemaleGraft SurvivalAgedMiddle AgedFollow-Up StudiesPrognosisRisk FactorsSurvival RateAdultGlomerular Filtration RateKidney Function TestsRisk Assessment

Stichwörter der Autor:innen

death with functioning graftelderly recipientgraft survivalkidney retransplantationpatient survival

Autor:innen und Institutionen

  • Department of Surgery, Section of Transplantation, Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, USA.
  • Department of Medicine, Section of Nephrology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.

ORCID-Profile: Syed S Mujtahedi, Colleen L Jay, Giuseppe Orlando, Robert J Stratta

Zitieren

APA

Mujtahedi, S. S., Jay, C. L., Sakhovskaya, N., Reeves-Daniel, A., Mena-Gutierrez, A., Webb, C. J., McCracken, E. K. E., Farney, A. C., Orlando, G., Vyas, J., Cabrales, A., & Stratta, R. J. (2025). Kidney Retransplantation in the Elderly: Are the Benefits Worth the Risks?. Clinical Transplantation. https://doi.org/10.1111/ctr.70129

Vancouver

Mujtahedi SS, Jay CL, Sakhovskaya N, Reeves-Daniel A, Mena-Gutierrez A, Webb CJ, et al. Kidney Retransplantation in the Elderly: Are the Benefits Worth the Risks?. Clinical Transplantation. 2025. doi:10.1111/ctr.70129

BibTeX
@article{Mujtahedi2025,
  author = {Mujtahedi, Syed S and Jay, Colleen L and Sakhovskaya, Natalia and Reeves-Daniel, Amber and Mena-Gutierrez, Alejandra and Webb, Christopher J and McCracken, Emily K E and Farney, Alan C and Orlando, Giuseppe and Vyas, Jigish and Cabrales, Arianna and Stratta, Robert J},
  title = {Kidney Retransplantation in the Elderly: Are the Benefits Worth the Risks?},
  journal = {Clinical Transplantation},
  year = {2025},
  doi = {10.1111/ctr.70129}
}
Kostenlos starten →